Reneo Pharmaceuticals Inc

NAS:RPHM (USA)  
$ 1.48 +0.01 (+0.68%) 10:08 PM EST
At Loss
P/B:
0.61
Market Cap:
$ 49.46M
Enterprise V:
$ -32.47M
Volume:
77.00K
Avg Vol (2M):
155.31K
Trade In:
Volume:
77.00K
At Loss
Avg Vol (2M):
155.31K

Business Description

Reneo Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US75974E1038
Description
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
Name Current Vs Industry Vs History
Cash-To-Debt 91.33
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -49.7
3-Year EPS without NRI Growth Rate -46.3
3-Year FCF Growth Rate -39.5
Name Current Vs Industry Vs History
5-Day RSI 41.79
9-Day RSI 41
14-Day RSI 41.05
6-1 Month Momentum % -1.86
12-1 Month Momentum % -74.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 29.82
Quick Ratio 29.82
Cash Ratio 29.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.3
Shareholder Yield % -127.73
Name Current Vs Industry Vs History
ROE % -70.09
ROA % -62.09
ROIC % -1770.6
ROC (Joel Greenblatt) % -6047.19
ROCE % -74.91

Financials (Next Earnings Date:2024-08-09 Est.)

RPHM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RPHM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Reneo Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.18
Beta 0.2
Volatility % 90.99
14-Day RSI 41.05
14-Day ATR ($) 0.070422
20-Day SMA ($) 1.5255
12-1 Month Momentum % -74.76
52-Week Range ($) 0.9801 - 9.21
Shares Outstanding (Mil) 33.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Reneo Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Reneo Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Reneo Pharmaceuticals Inc Frequently Asked Questions

What is Reneo Pharmaceuticals Inc(RPHM)'s stock price today?
The current price of RPHM is $1.48. The 52 week high of RPHM is $9.21 and 52 week low is $0.98.
When is next earnings date of Reneo Pharmaceuticals Inc(RPHM)?
The next earnings date of Reneo Pharmaceuticals Inc(RPHM) is 2024-08-09 Est..
Does Reneo Pharmaceuticals Inc(RPHM) pay dividends? If so, how much?
Reneo Pharmaceuticals Inc(RPHM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1